Works matching IS 1470269X AND DT 2013 AND VI 13 AND IP 4
Results: 14
Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 359, doi. 10.1038/tpj.2012.19
- By:
- Publication type:
- Article
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 325, doi. 10.1038/tpj.2012.14
- By:
- Publication type:
- Article
Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 318, doi. 10.1038/tpj.2012.12
- By:
- Publication type:
- Article
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 330, doi. 10.1038/tpj.2012.22
- By:
- Publication type:
- Article
Predicting inhaled corticosteroid response in asthma with two associated SNPs.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 306, doi. 10.1038/tpj.2012.15
- By:
- Publication type:
- Article
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 342, doi. 10.1038/tpj.2012.11
- By:
- Publication type:
- Article
The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 312, doi. 10.1038/tpj.2012.9
- By:
- Publication type:
- Article
Clinical and economic challenges facing pharmacogenomics.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 378, doi. 10.1038/tpj.2011.63
- By:
- Publication type:
- Article
Transgenic mouse model reveals an unsuspected role of the acetylcholine receptor in statin-induced neuromuscular adverse drug reactions.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 362, doi. 10.1038/tpj.2012.21
- By:
- Publication type:
- Article
ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 349, doi. 10.1038/tpj.2012.16
- By:
- Publication type:
- Article
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 335, doi. 10.1038/tpj.2012.13
- By:
- Publication type:
- Article
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 297, doi. 10.1038/tpj.2012.53
- By:
- Publication type:
- Article
Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 369, doi. 10.1038/tpj.2012.10
- By:
- Publication type:
- Article
Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 4, p. 354, doi. 10.1038/tpj.2012.18
- By:
- Publication type:
- Article